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Abstract
Rationale: Compared with control subjects, patients with chronic obstructive pulmonary
disease (COPD) have an increased incidence of falls and demonstrate balance deficits
and alterations in mediolateral trunk acceleration while walking. Measures of gait
variability have been implicated as indicators of fall risk, fear of falling, and future falls.
Objectives: To investigate whether alterations in gait variability are found in patients
with COPD as compared with healthy control subjects. Methods: Twenty patients with
COPD (16 males; mean age, 63.6 ± 9.7 yr; FEV1/FVC, 0.52 ± 0.12) and 20 control
subjects (9 males; mean age, 62.5 ± 8.2 yr) walked for 3 minutes on a treadmill while
their gait was recorded. The amount (SD and coefficient of variation) and structure of
variability (sample entropy, a measure of regularity) were quantified for step length,
time, and width at three walking speeds (self-selected and ±20% of self-selected
speed). Generalized linear mixed models were used to compare dependent variables.
Results: Patients with COPD demonstrated increased mean and SD step time across
all speed conditions as compared with control subjects. They also walked with a
narrower step width that increased with increasing speed, whereas the healthy control
subjects walked with a wider step width that decreased as speed increased. Further,
patients with COPD demonstrated less variability in step width, with decreased SD,
compared with control subjects at all three speed conditions. No differences in regularity
of gait patterns were found between groups. Conclusions: Patients with COPD walk
with increased duration of time between steps, and this timing is more variable than that
of control subjects. They also walk with a narrower step width in which the variability of
the step widths from step to step is decreased. Changes in these parameters have been
related to increased risk of falling in aging research. This provides a mechanism that
could explain the increased prevalence of falls in patients with COPD.
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Chronic obstructive pulmonary disease (COPD) leads to narrowing of the
airways, destruction of lung tissue, and dynamic hyperinflation of the lungs. COPD also
affects the structure and function of skeletal muscle (1–3). Patients with COPD
demonstrate muscle fatigue (4, 5) and muscle weakness (6) and also manifest gait
abnormalities (7–11). These gait abnormalities include biomechanical alterations at the
ankle, increased variability of mediolateral trunk movement, a shorter step length, more
time spent in double support, and slower cadence as compared with healthy control
subjects (8, 10–12). Moreover, patients with COPD have increased risk of falls
compared with healthy control subjects (13–17).
A number of gait abnormalities are related to increased fall risk in the general
population, including alterations in gait variability (18–24). Alterations in the variability of
step width have been associated with fall risk, prediction of falls, and fear of falling in
older adults (18–21). Step length variability is increased in older adult fallers as
compared with older adult nonfallers (22). Increased swing time and stride length
variability have predicted a higher risk ratio of future falls in a population of adults aged
70 years and older (23). Increased step time variability has been associated with
multiple falls (24).
Gait variability is defined as the natural stride-to-stride fluctuations present during
walking. Traditional methods of measuring variability include quantifying the amount of
variation (i.e., SD), providing information regarding the magnitude of variability around a
central mean. In addition, analysis of the structure of the output provides insight into the
control of the system. Temporal variations of a healthy biological system represent the
underlying physiological capability to make flexible adaptations to everyday demands
(25, 26). Disease and aging have been associated with a loss of flexible adaptations,
making movement patterns either too rigid or too irregular (27, 28). This can be
determined by assessing the amount and structure of variability.
Speed of walking is one everyday environmental situation that all persons encounter to
complete everyday activities. Gait variability will change while walking at a speed slower
or faster than one’s self-selected walking speed (29, 30). Because speed is commonly
used as a rehabilitation tool and is a predictor of survival (31), it is important to
understand how gait variability is affected by speed perturbations. Challenging the body
to walk at speeds outside the self-selected walking speed can reveal declines in gait or
associations in gait patterns that are otherwise camouflaged at their self-selected
walking speed (32).
The aim of the present study was to investigate whether changes in gait variability are
present in patients with COPD as compared with healthy control subjects. It was
hypothesized that patients with COPD would demonstrate alterations in the variability of
walking patterns as compared with age-matched healthy control subjects while walking
at a self-selected speed. It was postulated that patients with COPD would demonstrate
reduced variability and a more predictable/regular movement pattern that reflects a
more restricted and inflexible gait. Furthermore, to understand the effect of speed on
gait variability, different speed perturbations were used. If patients with COPD truly do

have less flexible and less adaptable movement patterns, this would be better
demonstrated at walking speeds that are slower or faster than their self-selected
walking speeds.

Methods
Study Subjects
A convenience sample of 20 patients with COPD and 28 healthy control subjects
was recruited from the University of Nebraska Medical Center and the Omaha Veterans
Affairs Medical Center outpatient clinics to participate in this study. Healthy control
subjects were recruited from the nearby community. The presence of COPD was
determined by previous diagnosis and confirmed with spirometry using an FEV 1/FVC
cutoff ratio less than 0.7 (33). Subjects were considered healthy if they had no reported
diagnosis of COPD. Smoking history was also collected and current smokers were not
excluded.
Subjects were excluded if they presented with a history of injury or disease that
affected their mobility or any other process limiting their ability to walk. In addition,
subjects were excluded if they presented with any comorbidity that may affect the
musculoskeletal, neurological, pulmonary, or cardiovascular systems and their ability to
walk. These included but were not limited to joint abnormalities, joint replacements,
acute/chronic lower back pain, multiple sclerosis, Parkinson’s disease, peripheral
arterial disease, and stroke. Patients with COPD were excluded if they required
supplemental oxygen or if they had been hospitalized or had experienced an acute
exacerbation within the past 3 months. All subjects were screened in person by a nurse
practitioner to ensure that they met the inclusion criteria. The institutional review boards
at both institutions approved the study, and all subjects provided written informed
consent.
Walk Observation Protocol
In the biomechanics laboratory, subjects changed into a form-fitting suit (i.e.,
wrestling singlet). Retroreflective markers were placed on the following anatomical
locations bilaterally: lateral and medial metatarsophalangeal joint, base of the second
toe, calcaneus, heel, lateral and medial malleoli, midshank, tibial tuberosity, lateral and
medial knee joint center, top of thigh, midthigh, greater trochanter, anterior and posterior
superior iliac spine, and sacrum (34) (Figure 1).
Subjects were then asked to walk on a treadmill at their self-selected pace. A
self-selected pace was defined for the subjects as a comfortable walking speed, a pace
at which they would walk from their vehicle to the building. Once subjects’ comfortable
walking speed was chosen, they were allowed to rest for a minimum of 2 minutes. They
returned to the treadmill to complete 3.5 minutes of walking on the treadmill at their selfselected pace. Three-dimensional marker positions from the last 3 minutes of walking
were recorded (60 Hz; Motion Analysis Corp., Santa Rosa, CA) (Figure 1).

Figure 1.(A) Thirty-three markers are placed on the subject for calculation of joint centers during walking.
(B) During the walking trials, the medial metatarsophalangeal joint, medial malleolus, and medial knee
markers are removed, leaving 30 retroreflective markers used during walking trials. (C) Infrared cameras
are placed throughout the laboratory. Calibrated cameras triangulate the position of each marker based
on the reflection of infrared light back to the camera lens off the retroreflective marker. The positions of
markers are used to calculate step time, length, and width.

The walking trials were repeated at two additional speeds: ±20% of subjects’ selfselected pace. The order of the last two speeds was randomized for all subjects. After
each walking trial, each subject was asked to provide a rating of perceived exertion
based on a 6- to 20-point Borg scale (35). Between trials, subjects rested for a minimum
of 2 minutes or as long as needed until they felt rested to prevent fatigue.
Healthy control subjects were matched one to one for speed with the patients
with COPD because speed can influence gait variability. In total, 20 patients with COPD
and 20 healthy control subjects were used in the data analysis (Table 1). Unfiltered
three-dimensional marker data were used to calculate three spatiotemporal time series
for each subject and each of the three speeds using custom MATLAB software
programs (MathWorks, Inc., Natick, MA).
Gait Analysis
Step length was calculated as the anteroposterior distance from the heel strike of
the right foot to the heel strike of the left foot and vice versa. Step time was calculated
by determining the frame number at heel strike of the right foot to the frame number of
the left foot heel strike. The total number of frames between the two events was then
multiplied by the inverse of the sampling frequency (1/60) to acquire step time (1/60
represents the inverse of the sampling frequency which was 60 Hz). This was repeated
for each right and left step. Step width was calculated as the mediolateral distance from
the heel strike of the right foot to the heel strike of the left foot and the same for

continuing contralateral and ipsilateral steps. This included extremely narrow steps,
leading to some step widths being expressed as a negative number.
Table 1. Demographics of subjects used for analysis
Control (n = 20)

COPD (n = 20)

9

16

Age, yr

62.5 (8.2)

63.6 (9.7)

0.69

Height, m

1.68 (0.10)

1.76 (0.11)

0.03*

Weight, kg

74.7 (15.5)

94.0 (32.7)

0.02*

Self-selected gait speed, m/s

0.95 (0.22)

0.80 (0.27)

0.06

Rate of perceived exertion
−20% pace

7.6 (1.8)

10.1 (2.2)

<0.001*

Rate of perceived exertion
self-selected pace

9.2 (1.8)

10 (2.7)

0.32

Rate of perceived exertion
+20% pace

10.7 (1.8)

11.7 (2.9)

0.25

FEV1/FVC

0.79 (0.06)

0.52 (0.12)

<0.001*

FEV1, % predicted

100.3 (16.2)

54.3 (19.2)

<0.001*

Smoking history

2 ex-smokers

7 ex-smokers

11 nonsmokers

9 current
smokers

6 not reported

3 nonsmokers

Male sex, n

P Value

1 not reported
Definition of abbreviation: COPD = chronic obstructive pulmonary disease.
Data are presented as mean (SD) or raw numbers.
*Significant (P < 0.05) difference between groups.

Generated time series for step length, step time, and step width included
consecutive right and left steps from the entire 3-minute walking trial. All the time series
were then cut to 250 steps. This is based upon the slowest-walking subject with the
least number of steps. Only three trials did not meet this requirement, and all were for
patients with COPD at the −20% walking speed; these trials contained 238, 236, and

206 steps and were therefore not included in the sample entropy (SampEn) calculation.
The following dependent variables were calculated for each time series: mean, SD,
coefficient of variation, and SampEn.
SampEn provides a measure of the regularity within the time series by measuring
the loss of information from point to point and has previously been described in detail
(36). A perfectly repeatable time series would elicit a SampEn value of approximately 0,
and a completely random time series would elicit a SampEn value extending toward
infinity. After examining the relative consistency of the group averages for several
combinations of parameters for the present study (36), r was chosen as 0.25 × SD of the
time series, and m was chosen as 2.
Time series were plotted and visually inspected for spikes or outliers greater than
3 SD. None were found. Mean, SD, coefficient of variation, and SampEn from the step
length, step time, and step width time series for both the healthy control subjects and
patients with COPD were calculated (see online supplement). Normality was examined
for each dependent variable.
A linear mixed model was used to assess differences in mean length, time, and
width between groups (patients with COPD vs. control subjects) and over the three
speed conditions (−20%, self-selected, and +20%). This modeling approach allowed us
to determine differences within and between groups while accounting for correlation due
to repeated measurements and adjusting for potentially confounding variables.
Generalized linear mixed models were used for variables that did not meet the normality
assumption. All interactions between speed and group were also investigated.
Adjustments for multiple comparisons were made using the simulation technique. Mean
differences (MDs) between groups or speeds and 95% confidence intervals (CIs) were
calculated. All statistics were performed using SAS software (SAS Institute, Inc., Cary,
NC). The significance level was set at P < 0.05.

Results
Group Comparisons
Patients with COPD demonstrated increased mean differences (MD, −0.082;
95% CI, −0.153 to 0.012) and SDs (MD, −0.30; 95% CI, −0.559 to 0.035) of step time
across all speed conditions; that is, they walked slower and with a greater range of
speeds than the control subjects (P = 0.02 and P = 0.03, respectively) (Figure 2). In
addition, patients with COPD demonstrated increased mean step width with increasing
speed, whereas the healthy control subjects decreased mean step width as speed
increased (P = 0.04) (Figure 3). Furthermore, patients with COPD demonstrated
decreased a SD of step width across all speed conditions (MD, 0.004; 95% CI, 0.001–
0.007; P = 0.007). Thus, patients with COPD use a wider step width that does not
decrease with increase in speed, as does the gait of the control subjects.

Figure 2.The (A) mean, (B) SD, (C) coefficient of variation, and (D) sample entropy of step time. Patients
with chronic obstructive pulmonary disease (COPD) had a greater mean and SD of step time as speed
increased. *Significant (P < 0.05) difference between groups across all speeds. Dotted horizontal
lines indicate significant (P < 0.05) differences in speed conditions across both groups.

Figure 3.The (A) mean, (B) SD, (C) coefficient of variation, and (D) sample entropy of step width. Mean
step width was narrower for patients with chronic obstructive pulmonary disease (COPD) across all
speeds than for healthy control subjects. The mean step width increased as speed increased in patients
with COPD; however, mean step width decreased in healthy control subjects as speed increased. In
addition, the step width SD was decreased in patients with COPD as compared with healthy control
subjects across all speeds. *Significant (P < 0.05) difference between groups across all speeds. A caret
(^) indicates an interaction (P < 0.05).

Speed Comparisons
Mean step length increased with increased speed, whereas step time decreased with
increased speed (P < 0.0001) for both groups. SD and coefficient of variation of step
length and step time decreased as speed increased for both groups (P < 0.001) (Figures
2 and 4). In addition, step time SampEn decreased as speed increased for both groups
(P < 0.001) (Figure 2).

Figure 4.The (A) mean, (B) SD, (C) coefficient of variation, and (D) sample entropy of step length. As the
mean step length increased with increasing speed, the SD and coefficient of variation decreased for both
groups. Dotted horizontal lines indicate significant (P < 0.05) differences in speed conditions across both
groups. COPD = chronic obstructive pulmonary disease.

Discussion
The present study demonstrates that patients with COPD have an increased
mean step time with increased variability (i.e., SD) across all speeds as compared with
control subjects. No differences in regularity of gait patterns were found between
groups. Also, in keeping with our hypothesis that if patients with COPD had less flexible
and less adaptable movement patterns, this would be more apparent at walking speeds
that differed from self-selected speeds (e.g., too slow or too fast). In this context,
patients with COPD demonstrated a narrower step width that increased as speed
increased, whereas the healthy control subjects had a wider step width that decreased
as speed increased. Furthermore, the narrow step width exhibited in patients with
COPD was in the context of reduced step width variability because the SD was
decreased across all speeds. Alterations in gait variability have been associated with

increased fall risk in the general population (18–21, 24). The increased step time
variability and decreased step width variability demonstrated by patients with COPD in
the present study may provide a mechanism that could account for at least part of the
increased fall risk in this population.
A greater mean and SD of step time has been associated with multiple falls over
a 12-month prospective study in older individuals (24). However, conflicting results have
also been published in which no association has been found between step time
variability and fall history in older individuals (19). Our present findings demonstrate that
patients with COPD walk with an increased step time and intrasubject variability in step
timing across all speeds compared with control subjects. Moreover, patients with COPD
have an increased risk of falls compared with healthy control subjects (13–17). The
degree to which increased step time variability may account for previous falls, future
falls, or fear of falling in patients with COPD has not been investigated.
Step time variability is also associated with other individual characteristics
beyond fall history. Women have a stronger association between age and step time
variability when gait speed is not controlled, especially as age increases (37). Stride
(i.e., two steps) time variability is increased in older adults who are frail (38) or
cognitively impaired (39). Further, it is associated with central nervous system
impairments (40) and subclinical brain vascular abnormalities (41). Thus, future
investigations should explore the association between increased step time variability
and falls in patients with COPD while controlling for frailty and cognition.
Just as step time variability has been associated with fall history, step width
variability has been associated with fall history and fear of falling (18, 19, 21). Patients
with COPD walked with a narrower step width that increased with increasing speed,
whereas the healthy control subjects walked with a wider step width that decreased as
speed increased. Further, patients with COPD demonstrated less variability in step
width, expressed as decreased SD, than control subjects at all three speed conditions.
A reduced variability and a narrower step width lead to a walking pattern that has a
smaller base of body support and greater likelihood to result in a crossover gait. A
decrease in the SD of step width may indicate the inability to compensate for instability,
thus predisposing an individual to a fall (18, 42). Both increases and decreases in step
width variability are associated with fall history in older adults (19, 21).
The present findings are not consistent with our previous report that patients with
COPD walk with a wider step width than their age-matched control subjects (12). This is
likely due to the calculation of step width. In our previous study, step width was
calculated as the absolute distance between right and left heel position and did not
consider any step widths so narrow as to cause a negative step width (12). The present
study included steps in which the step width was negative. In one control subject,
negative step widths ranged from 2 to 12% over the three trials, whereas negative step
widths in the patient with COPD ranged from 11 to 34%. The average negative step
widths were −0.0087 mm for the patient with COPD and −0.007 mm for the control

subject. An additional five subjects experienced one to two negative step widths during
the trials.
Modulating step width during walking is considerably different from modulating
step time or step length. Step width occurs in the mediolateral (frontal) plane of motion.
Mediolateral movements while walking have been suggested to require increased
cognitive regulation of movement to adjust for balance disturbances in that plane of
motion, thus leading to altered variability in this direction of movement (43, 44). This
could imply that patients with COPD may have a deficit in controlling the mediolateral
direction. Range and root mean square of displacement of the center of mass while
standing in patients with COPD is increased in the mediolateral direction as compared
with age-matched control subjects (13). When sensory systems were challenged (e.g.,
eyes closed, standing on a foam pad or narrow base), patients with COPD continued to
demonstrate greater displacement of the center of mass in the mediolateral direction
(13). Furthermore, mediolateral trunk acceleration while walking in patients with COPD
demonstrated a greater variability between strides (8). On the basis of evidence of
increased falls and fall risk in patients with COPD (13–15, 45–47), patients with COPD
could require additional cognitive resources for mediolateral control.
Future investigations should be focused on step width and step time variability in
patients with COPD and their potential association with fall risk. Further, pulmonary
rehabilitation programs focused on restoration of functional limitations should consider
the implementation of exercises targeted at mediolateral control and/or balance
recovery strategies. Although implementation of balance training into pulmonary
rehabilitation has been shown to be feasible and effective (48, 49), home exercise
protocols designed to progress balance-challenging activities may improve the scores
on these clinical assessments of balance in patients with COPD as well (50).
As stated earlier, gait variability is defined as the natural stride-to-stride
fluctuations present during walking, but it can be measured several ways. To draw
comprehensive conclusions regarding the variability of movement, one must examine
both the amount and the structure of the variability. In the present study, the amount of
variation (SD and coefficient of variation) was sensitive to changes between groups and
speeds, whereas structure of variation (SampEn) was not sensitive to differences
between groups. Spatiotemporal variability measures have strong to moderate
construct, predictive, convergent, and predictive validity of falling, whereas most
nonlinear measures do not (51). Future work could also include the variability of
kinematics of gait in patients with COPD. It is possible that the amount of variability of
joint angles is altered in patients with COPD as compared with healthy control subjects.
This has been found in older adults as compared with young adults (52). Kinematics
may represent a more global parameter of gait rather than the general spatiotemporal
gait parameters in the present study.
Limitations

This study has limitations. The first limitation is the limited and potentially
heterogeneous sample of patients with COPD recruited to participate in this study
(53, 54). The present study included a sample size of 40 (20 per group). Because
biomechanical motion capture is accurate to within 0.5 mm, biomechanical studies
typically use smaller sample sizes (55). Recently, several potential phenotypes
(subsets) of COPD have been identified, including a clinical phenotype (age, sex,
smoking history), physiological (rapid decline in FEV1), radiographic or imaging
(structural abnormalities), acute exacerbation of COPD, systemic inflammation, and the
presence of comorbidities (cardiovascular disease, metabolic syndrome, osteoporosis,
diabetes, depression) (53, 54). Although all patients were screened by a nurse
practitioner before inclusion in the study, it is possible that not all comorbidities were
included in our exclusion criteria. Moreover, it may be that each phenotype presents
with a different gait pattern and that the sample size of the present study did not allow
for this analysis.
Second, owing to the pathophysiology of the disease, patients with COPD are
limited in the length of time for which they can walk on the treadmill. This limits the data
length that can be acquired during a trial. Entropy data measures respond differently
with longer length of datasets (56). To abate this limitation, SampEn was used because
this is robust against different data lengths and tends to respond better to short data
lengths (36).
Third, the speed perturbations of ±20% of the subjects’ self-selected walking
speed may not have been challenging enough. Based on the reported rating of
perceived exertion, the fastest speed was not nearly close to the subjects’ maximal
walking speed. Patients with COPD reported an average of 11.7 on the Borg scale,
whereas the healthy control subjects reported 10.7, not significantly different. A rating of
11 is considered “fairly light,” and 13 is categorized as “somewhat hard.” Ratings closer
to 16 would suggest working in a range closer to maximal level. Fourth, it is possible
that several of the patients with COPD presented with muscle weakness that was not
measured. Lower-extremity muscle weakness can alter gait biomechanics as well as
gait variability (57).
Last, there are physiological and biomechanical differences between overground
and treadmill walking (58–67). The treadmill could be considered a constraint because it
limits fluctuations in walking that are normally present in overground walking. Other
measures have shown conflicting results regarding the difference in variability between
treadmill and overground walking (68–71). Therefore, it is possible that the variability of
the gait data is affected by the use of the treadmill.
Conclusions
Patients with COPD demonstrated altered gait variability. Patients with COPD
walk with increased duration between steps, and this timing is more variable than it is in
control subjects. Patients with COPD also walk with a decreased step width in which the
variability of the step widths from step to step is decreased as compared with control

subjects. These differences were manifest at all gait speeds tested. This provides a
mechanism that could account for at least part of the increased fall risk present in
patients with COPD.
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